Tohoku J. Exp. Med., 2011, 223(2)

A Novel PAX4 Mutation in a Japanese Patient with Maturity-Onset Diabetes of the Young

WAKAKO JO,1 MACHIKO ENDO,2 KATURA ISHIZU,1 AKIE NAKAMURA1 and TOSHIHIRO TAJIMA1

1Department of Pediatrics, Hokkaido University School of Medicine, Sapporo, Japan
2Department of Pediatrics, Hakodate Goryokaku Hospital, Hakodate, Japan

Maturity-onset diabetes of the young (MODY) is a genetically and clinically heterogeneous type of diabetes mellitus, characterized by early onset (often before 25 years of age) and absence of pancreatic autoimmunity markers. Paired-homeodomain transcription factor 4 (PAX4) functions as a transcriptional repressor and is involved in the differentiation of insulin-secreting β-cells. Here we identified a novel PAX4 mutation in a Japanese patient with MODY. A 15-year-old, non-obese boy was admitted to our hospital because of polyuria and polydipsia. Laboratory evaluation showed an elevated fasting glucose level; however, islet cell antibodies and glutamic acid decarboxylase antibodies were not detected in the patient's serum. The proband's father had been diagnosed as having type 2 diabetes at age of 30 years. We therefore analyzed several candidate genes of MODY, and identified a novel mutation of a 39-base heterozygous deletion in exon 3 (c.374-412 del39) of PAX4 in the proband and his father. This mutation may cause exon 3 skipping that results in a frameshift, thereby producing a premature stop codon in exon 5. As this mutant PAX4 lacks a part of the homeodomain that is critical for binding to the target gene, this mutant was thought to lose the transcriptional repressor function. As expected, luciferase-reporter assays revealed that the mutant PAX4 could not repress the activities of insulin and glucagon gene promoters, unlike the wild-type PAX4 that repressed the promoter activities. The present study demonstrates that a novel mutation of PAX4 is likely to be associated with diabetes in this Japanese family.

keywords —— Maturity onset of diabetes of young (MODY); PAX4; mutation

===============================

Tohoku J. Exp. Med., 2011, 223, 113-118

Correspondence: Toshihiro Tajima, M.D., Ph.D., Department of Pediatrics, Department of Pediatrics, Hokkaido University School of Medicine, N15, W7, Sapporo 060-0835, Japan.

e-mail: tajeari@med.hokudai.ac.jp